Menu
GeneBe

TLK2

tousled like kinase 2

Basic information

Region (hg38): 17:62458657-62615481

Links

ENSG00000146872NCBI:11011OMIM:608439HGNC:11842Uniprot:Q86UE8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual disability, autosomal dominant 57 (Moderate), mode of inheritance: AD
  • intellectual disability, autosomal dominant 57 (Strong), mode of inheritance: AD
  • intellectual disability, autosomal dominant 57 (Definitive), mode of inheritance: AD
  • intellectual disability, autosomal dominant 57 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, autosomal dominant 57ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic27479843; 29861108

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TLK2 gene.

  • not provided (88 variants)
  • Intellectual disability, autosomal dominant 57 (52 variants)
  • Inborn genetic diseases (14 variants)
  • TLK2-related condition (5 variants)
  • not specified (3 variants)
  • Neurodevelopmental disorder (3 variants)
  • See cases (2 variants)
  • Intellectual disability (1 variants)
  • TLK2-Related Disorder (1 variants)
  • Autism;Intellectual disability (1 variants)
  • Developmental disorder (1 variants)
  • TLK2-related neurodevelopmental disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLK2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
1
clinvar
6
missense
1
clinvar
14
clinvar
49
clinvar
2
clinvar
66
nonsense
14
clinvar
6
clinvar
20
start loss
0
frameshift
10
clinvar
3
clinvar
2
clinvar
15
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
6
clinvar
4
clinvar
1
clinvar
11
splice region
1
6
3
10
non coding
1
clinvar
1
clinvar
6
clinvar
3
clinvar
11
Total 32 28 61 10 1

Variants in TLK2

This is a list of pathogenic ClinVar variants found in the TLK2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-62479268-AGCG-A not specified Likely benign (Jan 02, 2020)1301690
17-62479291-G-T Uncertain significance (Jun 21, 2022)1806738
17-62479511-T-TGGGGCCG Intellectual disability, autosomal dominant 57 Conflicting classifications of pathogenicity (Jan 01, 2024)1694856
17-62479525-G-C Likely benign (Feb 01, 2024)2648025
17-62481145-G-T Inborn genetic diseases Uncertain significance (Apr 26, 2023)2541030
17-62481152-C-T Likely benign (Jun 01, 2022)2648026
17-62481156-C-T Intellectual disability, autosomal dominant 57 Likely pathogenic (Oct 02, 2021)1320192
17-62481159-C-T Intellectual disability, autosomal dominant 57 Uncertain significance (Jul 07, 2020)992409
17-62481159-CG-C Intellectual disability, autosomal dominant 57 Pathogenic (Jan 08, 2021)1285495
17-62481162-C-T Intellectual disability, autosomal dominant 57 Pathogenic (Oct 15, 2018)617935
17-62481181-G-C Uncertain significance (Apr 01, 2021)1176057
17-62481192-G-A Inborn genetic diseases Likely benign (Jan 19, 2024)3177847
17-62481207-GT-G Intellectual disability, autosomal dominant 57 Uncertain significance (Mar 03, 2022)3068634
17-62520785-A-G Uncertain significance (Apr 01, 2023)2648027
17-62520815-G-A Inborn genetic diseases Uncertain significance (Dec 09, 2023)3177845
17-62520852-G-A not specified Uncertain significance (Mar 13, 2024)3233988
17-62522199-G-A Uncertain significance (Aug 01, 2019)871756
17-62522213-A-G Intellectual disability Uncertain significance (May 28, 2020)977159
17-62522214-A-G Uncertain significance (Nov 28, 2022)2503374
17-62522224-T-G Uncertain significance (Feb 14, 2020)1311944
17-62522231-C-T Intellectual disability, autosomal dominant 57 Pathogenic (Oct 15, 2018)617928
17-62522237-C-T Uncertain significance (Mar 22, 2023)1308771
17-62522252-G-T Intellectual disability, autosomal dominant 57 Pathogenic (Oct 15, 2018)617923
17-62523126-A-G Likely benign (Apr 01, 2024)2648028
17-62523136-A-C Uncertain significance (Jan 24, 2023)2573898

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TLK2protein_codingprotein_codingENST00000346027 21156824
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.005.65e-8125736051257410.0000199
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense4.491484010.3690.00002174917
Missense in Polyphen12113.470.105751576
Synonymous0.02591451450.9970.000008021353
Loss of Function6.62255.00.03640.00000351609

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002670.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.0003290.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Serine/threonine-protein kinase involved in the process of chromatin assembly and probably also DNA replication, transcription, repair, and chromosome segregation. Phosphorylates the chromatin assembly factors ASF1A AND ASF1B. Phosphorylation of ASF1A prevents its proteasome-mediated degradation, thereby enhancing chromatin assembly. Negative regulator of amino acid starvation-induced autophagy. {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:11470414, ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:12955071, ECO:0000269|PubMed:20016786, ECO:0000269|PubMed:22354037, ECO:0000269|PubMed:9427565}.;
Pathway
miRNA Regulation of DNA Damage Response;DNA Damage Response (Consensus)

Recessive Scores

pRec
0.0999

Intolerance Scores

loftool
0.156
rvis_EVS
-0.27
rvis_percentile_EVS
34.32

Haploinsufficiency Scores

pHI
0.367
hipred
Y
hipred_score
0.817
ghis
0.564

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
H
gene_indispensability_pred
N
gene_indispensability_score
0.451

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tlk2
Phenotype

Gene ontology

Biological process
regulation of chromatin assembly or disassembly;chromatin organization;protein phosphorylation;cellular response to DNA damage stimulus;cell cycle;chromosome segregation;negative regulation of autophagy;peptidyl-serine phosphorylation;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;intracellular signal transduction;cellular response to gamma radiation
Cellular component
nucleus;intermediate filament;perinuclear region of cytoplasm
Molecular function
protein serine/threonine kinase activity;protein binding;ATP binding